Adamo, Vincenzo
University of Messina
7 papers on CoChatORCID 0000-0003-2074-2418
Most cited papers
- Verified
Integrated analysis of concomitant medications and oncological outcomes from PD-1/PD-L1 checkpoint inhibitors in clinical practice
Cortellini, A., Tucci, M., Adamo, V., Stucci, L. S., Russo, A., Tanda, E. T., Spagnolo, F., Rastelli, F., Bisonni, R., Santini, D., et al. (2020) · Journal for ImmunoTherapy of Cancer
Cancer Immunotherapy and BiomarkersFerroptosis and cancer prognosis
Cited by 275
- Verified
A decade of EGFR inhibition in EGFR-mutated non small cell lung cancer (NSCLC): Old successes and future perspectives
Russo, A., Franchina, T., Rita Ricciardi, G. R., Picone, A., Ferraro, G., Zanghì, M., Toscano, G., Giordano, A., & Adamo, V. (2015) · Oncotarget
Lung Cancer Treatments and MutationsHER2/EGFR in Cancer Research
Cited by 173
- Verified
Breast safety and efficacy of genistein aglycone for postmenopausal bone loss: a follow-up study
Marini, H., Bitto, A., Altavilla, D., Burnett, B. P., Polito, F., Di Stefano, V., Minutoli, L., Atteritano, M., Levy, R. M., D'Anna, R., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism
Phytoestrogen effects and researchBone health and osteoporosis research
Cited by 167
- Verified
Heterogeneous Responses to Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors (TKIs) in Patients with Uncommon EGFR Mutations: New Insights and Future Perspectives in this Complex Clinical Scenario
Russo, A., Franchina, T., Ricciardi, G., Battaglia, A., Picciotto, M., & Adamo, V. (2019) · International Journal of Molecular Sciences
Lung Cancer Treatments and MutationsHER2/EGFR in Cancer Research
Cited by 110
- Verified
NSCLC and HER2: between lights and shadows
Ricciardi, G. R. R., Russo, A., Franchina, T., Ferraro, G., Zanghì, M., Picone, A., Scimone, A., & Adamo, V. (2014) · Journal of Thoracic Oncology
Lung Cancer Treatments and MutationsHER2/EGFR in Cancer Research
Cited by 78
- Verified
Insertional mutagenesis and development of malignancies induced by integrating gene delivery systems: Implications for the design of safer gene-based interventions in patients
Romano, G., Matino, I. R., Pentimalli, F., Adamo, V., & Giordano, A. (2009) · Drug News & Perspectives
Virus-based gene therapy researchRNA Interference and Gene Delivery
Cited by 38
- Verified
Rapid Acquisition of T790M Mutation after Treatment with Afatinib in an NSCLC Patient Harboring EGFR Exon 20 S768I Mutation
Russo, A., Franchina, T., Ricciardi, G. R. R., & Adamo, V. (2017) · Journal of Thoracic Oncology
Lung Cancer Treatments and MutationsHER2/EGFR in Cancer Research
Cited by 7
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free